189852
Effect of breastfeeding duration on lung function is modified by maternal history of asthma and atopy
Despite its known beneficial effects, there have been conflicting reports on whether breastfeeding confers protection from asthma in late childhood. In the Isle of Wight birth cohort (n=1456), breastfeeding practices and duration were prospectively assessed at birth and at the 1 and 2 year visits. Breastfeeding duration was categorized as “not breastfed” (n=196); “<2 months” (243); “2 and <4 months” (142) and “>=4 months” (374). Lung function was assessed at age 10 (n=1033): forced vital capacity (FVC); forced expiratory volume in 1 second (FEV1); FEV1/FVC ratio; and peak expiratory flow (PEF). Maternal history of asthma and allergy were assessed at birth. Birthweight, sex, and current height and weight were adjusted for. FVC was increased by 53.0 +/- 20.1ml (p=0.008); FEV1 by 37.5 +/- 19.0ml (p=0.049); and PEF by 160.3 +/- 62.9ml (p=0.01) in those who were breastfed for at least 4 months compared to those who were not. Stratification showed that this effect was modified by maternal history of asthma and atopy. Compared to those who were not breastfed, children of non-atopic non-asthmatic mothers who were breastfed for at least 4 months showed a significantly increased FVC (60.0 +/- 23.3ml; p=0.01) and PEF (164.6 +/- 75.9ml; p=0.03). This positive effect on lung function was not found in children with atopic non-asthmatic and atopic asthmatic mothers. Breastfeeding for at least 4 months enhances lung growth in children. Maternal history of asthma and atopy abolishes this effect. Future studies need to elucidate the mechanisms that drive these findings.
Learning Objectives: At the end of the presentation, participants should be able to identify the benefits of prolonged breastfeeding in lung growth. Participants will also recognize the difference in effect depending on maternal history of allergic diseases and thus recognize the impact this may have on public health recommendations for respiratory health.
Presenting author's disclosure statement:Qualified on the content I am responsible for because: Student member of Delta Omega
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|